Stock Events

Stock Events

Australian Clinical Labs Limited (ACL.AU) Q3 2024 Earnings

28AugConfirmed

Nov 22

Q4 2022

Q1 2024

Q3 2024

0

0.04

0.07

0.11

Details

Expected EPS

0.07859111340358116

Actual EPS

0.1051156141772898

Surprise EPS

0.03

Surprise Percent

+33.75%

Description

Australian Clinical Labs Limited (ACL.AU) has reported earnings of 0.1051156141772898 per share for Q3 2024.

1 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.